ImetelChat

Thanks, BP - this news along with the confirmation that DR Rizo keeps all of her stock options should also put to rest any inference that she is leaving a sinking ship.

Excellent news BP - thanks for sharing.

Geron Corporation
2018 Equity Incentive Plan
Approved by the Stockholders: May 11, 2021

Eligible Award Recipients. Employees, Directors, and Consultants are eligible to receive Stock Awards under this Plan.

If anyone has insight into the trials, it's Faye Feller, ergo, if there's evidence that the data is disappointing, she would know it. "Since coming to Geron, she has played a strategic role in designing and driving execution of our Phase 3 clinical trials. In addition, she serves as the primary medi...

My two cents - pre-TLR the pps will be between $2.4 & $5. Post TLR (with similar results to PII) - $4 - $12. Big gains in pps will occur between 2023 and 2025. By EOY 2024 the MC should be at least 15B, the top is anybody's guess. Keep an eye on the short position. If they start covering, it's a ver...

Cheng-ho,

Check out the SPDR S&P Biotech ETF (XBI) index fund - how do you explain Geron outperforming this index fund over the past year.

Thanks in advance.

MG

Ditto.

bp - you've done a wonderful job. Thanks very much for your efforts. I would gladly contribute $100 to keep this site going.

MG

Scarlett has become a believer in having an ATM at the ready. Unfortunately Geron's history would have been considerably less painful if Greenwood & Okarma had an ATM ready for the run to $73! Hopefully Scarlett is expecting a significant spike in the near future.

Well said HTB. The current obsession with JS in SA is beyond overdone. We're due for a little unanticipated good luck. Holding strong.